Evaluating the Use and Timing of Opioids for the Treatment of Migraine Headaches in the Emergency Department

Journal of Emergency Medicine

Volumn 36, Issue 4, 2009, Pages 333-337

  Tornabene, Stephen V ^a   Deutsch, Reena ^b   Davis, Daniel P ^b   Chan, Theodore C ^b   Vilke, Gary M ^b  

^a Kaiser Permanente Oakland ^*  (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

emergency department; headache; migraine; opioid; repeater

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANXIOLYTIC AGENT; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CODEINE; DIAZEPAM; DIHYDROERGOTAMINE; FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; HYDROXYZINE; KETOROLAC; LORAZEPAM; METOCLOPRAMIDE; MORPHINE; ONDANSETRON; OPIATE; OXYCODONE; PARACETAMOL; PETHIDINE; PREDNISOLONE; PROCHLORPERAZINE MALEATE; PROMETHAZINE; STEROID; TRIPTAN DERIVATIVE; VALPROIC ACID;

ADULT; ARTICLE; DRUG USE; EMERGENCY WARD; EVALUATION; FEMALE; HEADACHE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIGRAINE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT READMISSION; POLYPHARMACY; RECURRENCE; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; UNITED STATES;

EID: 64849088331     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.07.068     Document Type: Article

References (19)

1. Hu X., Markeson L., Lipton R., et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159 (1999) 813-818
2. Edmeads J., and Mackell A. The economic impact of migraine: an analysis of direct and indirect costs. Headache 42 (2002) 501-509
3. Vinson D.R., Hurtado T.R., Vandenberg J.T., et al. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med 41 (2003) 90-97
4. Vinson D.R. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 39 (2002) 334-337
5. Silberstein S. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
6. Colman I., Rothney A., Wright S., et al. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology 62 (2004) 1695-1700
7. Maizels M. Health resource utilization of the emergency department headache "repeater". Headache 42 (2002) 747-753
8. Chan B., and Ovens H. Chronic migraineurs: an important subgroup of patients who visit emergency departments frequently. Ann Emerg Med 43 (2004) 238-242
9. Ziegler D.K. Opioids in headache treatment: is there a role?. Neurol Clin 15 (1997) 199-207
10. Tamayo-Sarver J., Dawson N., Hinze S., et al. The effect of race/ethnicity and desirable social characteristics on physicians' decisions to prescribe opioid analgesics. Acad Emerg Med 10 (2003) 1239-1248
11. Lanser P., and Gesell S. Pain management: the fifth vital sign. Healthc Benchmarks 8 (2001) 68-70, 62.
12. Scherl E.R., and Wilson J.F. Comparison of dihyroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 35 (1995) 256-259
13. Duarte C., Dunaway F., Turner L., et al. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache, a randomized, prospective, double-blind trial. Ann Emerg Med 21 (1992) 1116-1121
14. Lane P.L., McLellan B.A., and Baggoley C.J. Comparative efficiency of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 18 (1989) 360-365
15. Maizels M. Headache evaluation and treatment by primary care physicians in an emergency department in the era of triptans. Arch Intern Med 161 (2001) 1969-1973
16. Centers for Disease Control and Prevention. Visits to U.S. emergency departments at all-time high; number of departments shrinking [press release May 26, 2005]. http://www.cdc.gov/od/oc/media/pressrel/r050526.htm
17. Langemark M., and Olesan J. Drug abuse in migraine patients. Pain 19 (1984) 81-86
18. Salomone J., Thomas R., Althoff J., et al. An evaluation of the role of the ED in the management of migraine headaches. Am J Emerg Med 12 (1994) 134-137
19. Lipton R., Diamond S., Reed M., et al. Migraine diagnosis and treatment: results from the American migraine study II. Headache 41 (2001) 638-645